Richard Jones, the current CEO of Adrenomed AG, has a strong background in the biotech industry, including roles as CEO at various companies like BrYet Limited, Fusion Antibodies, and Holostem Terapie Avanzate S.r.l. Richard has also held senior leadership positions at Akcea Therapeutics and GSK, with a focus on commercialization, rare diseases, and oncology. Richard holds a PhD in Molecular Toxicology/Oncology from the University of Surrey.
Current role
Co-founder And Chief Executive Officer (ceo) at Action Face
Chief Executive Officer (CEO) at Trackhawk Foundation
Chief Executive Officer (ceo)- Agri at PI Industries Ltd
Chief Executive Officer (ceo) at DFREIGHT Shipping & Logistics Solution
Founder and Chief Executive Officer (CEO) at Nirvana Solutions
Access the worlds's biggest network of public org charts
Learn more